- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Luna will discuss preliminary financial results, business developments and outlook
Luna Innovations Incorporated (NASDAQ: LUNA), a company focusing on sensing & instrumentation and nanotechnology, will provide a corporate update in a conference call with investors on January 11, 2010. The company will discuss its preliminary expectations for fourth quarter operating results, current business developments, the company's reorganization plan and expected emergence from Chapter 11, and the company's business focus for the future. The call will be held on January 11, 2010, at 1:30 p.m. (EST).
The investor conference call will be available via live webcast on the Luna Innovations' website at www.lunainnovations.com under the tab "Investor Relations." To participate by telephone, the domestic dial-in number is 1.800.299.7928 and the international dial-in number is 1.617.614.3926. The participant access code is 97312544. Investors are advised to dial in at least five minutes prior to the call to register. The webcast will be archived on the company's website under "Webcasts and Presentations" for 30 days following the conference call.
About Luna Innovations
Luna Innovations Incorporated (www.lunainnovations.com) is focused on sensing and instrumentation, and pharmaceutical nanomedicines. Luna develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. Its products are used to measure, monitor, protect and improve critical processes. Through its disciplined commercialization business model, Luna has become a recognized leader in transitioning science to solutions. Luna is headquartered in Roanoke, Virginia.
For more information, please click here
Copyright © Business WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017